No Picture
News

Poised for Significant Growth and Profitability, BioMarin Shares Company Highlights During R&D Day on November 14th in New York

Valoctocogene Roxaparvovec on Track for US and EU Regulatory Submissions by Year EndVosoritide Sustains Height Gain in Phase 2 Study, Phase 3 Topline Results Expected by Year EndNext Two IND Candidates Identified: 3rd Gene Therapy Candidate in Heredita… […]

No Picture
News

Icon Group Expands Cancer Care Capabilities with Purchase of Varian Adaptive Therapy Solution

PALO ALTO, Calif., Oct. 30, 2019 /PRNewswire/ — Icon Group, Australia’s largest dedicated provider of cancer care, with a growing reach into New Zealand and Asia, has made a purchase order to further improve the quality of cancer care treatment acr… […]

No Picture
News

ValGenesis Expands Operations in Canada by Establishing New Subsidiary ValGenesis Canada Inc., in Toronto, ON

SAN FRANCISCO, Oct. 1, 2019 /PRNewswire/ — ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Solutions, today announced the opening of its new subsidiary in Ontario, Canada, as part of its global expansion plan to pr… […]

No Picture
News

Paragon Genomics Establishes Subsidiary to Market Its Advanced CleanPlex® NGS Target Enrichment Solutions in China

– New Subsidiary Supports Paragon’s Rapidly Growing Business in China Providing CleanPlex® Ready-to-Use and Custom NGS Panels for Illumina, Ion Torrent and MGI Sequencers- China Subsidiary Selected for Leading Innovator’s Grant Providing Business Per… […]

No Picture
News

Invitae Expands Detect Program to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients

– Professional guidelines recommend genetic testing for all pancreatic cancer patients — Detect sponsored testing programs are designed to overcome barriers to testing and connect patients to earlier diagnosis and treatments –

SAN FRANCISCO, Sept. 9… […]

No Picture
News

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at Sylvester Comprehensive Cancer Center

PALO ALTO, Calif., Aug. 28, 2019 /PRNewswire/ — Varian (NYSE: VAR) has completed the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at Sylvester Comprehensive Cancer Center at the University of Miami Miller… […]

No Picture
News

Portola Launches European Sales of Ondexxya® (Andexanet Alfa) with First Orders in Europe

– Expands Patient Access to the First and Only Factor Xa Reversal Agent Approved in Europe for Life-Threatening Bleeds Associated with the Use of Rivaroxaban or Apixaban –

SOUTH SAN FRANCISCO, Calif., Aug. 6, 2019 /PRNewswire/ — Portola Pharmaceutic… […]